These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 11286153)

  • 1. Changing the practice of cardiovascular medicine.
    Braunwald E
    Atheroscler Suppl; 2001 Feb; 2(1):27-30. PubMed ID: 11286153
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The therapeutic gap--compliance with medication and guidelines.
    Feely J
    Atherosclerosis; 1999 Sep; 147 Suppl 1():S31-7. PubMed ID: 10575060
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical relevance of statins: their role in secondary prevention.
    Tonkin AM
    Atheroscler Suppl; 2001 Feb; 2(1):21-5. PubMed ID: 11286152
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Lowering cholesterol in the elderly--yes, no, or maybe?].
    Gogol M
    MMW Fortschr Med; 2006 Mar; 148(12):40-3. PubMed ID: 16626005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should intensive cholesterol lowering play a role in the management of acute coronary syndromes?
    Waters DD; Azar RR
    Am J Cardiol; 2000 Oct; 86(8B):35J-42J; discussion 42J-43J. PubMed ID: 11081447
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential use of 10-year and lifetime coronary risk information for preventive cardiology prescribing decisions: a primary care physician survey.
    Persell SD; Zei C; Cameron KA; Zielinski M; Lloyd-Jones DM
    Arch Intern Med; 2010 Mar; 170(5):470-7. PubMed ID: 20212185
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W; Forder P; Simes J; Hunt D; Tonkin A;
    Am Heart J; 2003 Apr; 145(4):643-51. PubMed ID: 12679760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ongoing clinical trials of statins.
    Gotto AM
    Am J Cardiol; 2001 Aug; 88(4A):36F-40F. PubMed ID: 11520486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Statins in primary prevention of coronary heart disease].
    Paulweber B
    Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical outcomes, risk stratification and practice patterns of unstable angina and myocardial infarction without ST elevation: Prospective Registry of Acute Ischaemic Syndromes in the UK (PRAIS-UK).
    Collinson J; Flather MD; Fox KA; Findlay I; Rodrigues E; Dooley P; Ludman P; Adgey J; Bowker TJ; Mattu R
    Eur Heart J; 2000 Sep; 21(17):1450-7. PubMed ID: 10952837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medical lipid-regulating therapy: current evidence, ongoing trials and future developments.
    Evans M; Roberts A; Davies S; Rees A
    Drugs; 2004; 64(11):1181-96. PubMed ID: 15161326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Benefits of pravastatin on cardiovascular events and mortality in older patients with coronary heart disease are equal to or exceed those seen in younger patients: Results from the LIPID trial.
    Hunt D; Young P; Simes J; Hague W; Mann S; Owensby D; Lane G; Tonkin A
    Ann Intern Med; 2001 May; 134(10):931-40. PubMed ID: 11352694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of statins in acute coronary syndromes: managing the unmet need.
    Jackson G
    Int J Clin Pract; 2000 Sep; 54(7):445-9. PubMed ID: 11070569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimizing lipid management in patients with acute coronary syndromes.
    Pepine CJ
    Am J Cardiol; 2003 Feb; 91(4A):30B-35B. PubMed ID: 12615296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid lowering drug therapy in patients with coronary heart disease from 24 European countries--Findings from the EUROASPIRE IV survey.
    Reiner Ž; De Backer G; Fras Z; Kotseva K; Tokgözoglu L; Wood D; De Bacquer D;
    Atherosclerosis; 2016 Mar; 246():243-50. PubMed ID: 26812002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of Nonuse of a High-Potency Statin After an Acute Coronary Syndrome: Insights From the Stabilization of Plaques Using Darapladib-Thrombolysis in Myocardial Infarction 52 (SOLID-TIMI 52) Trial.
    Eisen A; Cannon CP; Braunwald E; Steen DL; Zhou J; Goodrich EL; Im K; Dalby AJ; Spinar J; Daga S; Lukas MA; O'Donoghue ML
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28077384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients study.
    Pedersen TR; Jahnsen KE; Vatn S; Semb AG; Kontny F; Zalmai A; Nerdrum T
    Clin Ther; 2000 Aug; 22(8):949-60. PubMed ID: 10972631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized clinical trials and recent patterns in the use of statins.
    Wang TJ; Stafford RS; Ausiello JC; Chaisson CE
    Am Heart J; 2001 Jun; 141(6):957-63. PubMed ID: 11376310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical relevance of statins: instituting treatment early in acute coronary syndrome patients.
    Thompson PL
    Atheroscler Suppl; 2001 Feb; 2(1):15-9. PubMed ID: 11286151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The UK National Health Service: delivering equitable treatment across the spectrum of coronary disease.
    Hawkins NM; Scholes S; Bajekal M; Love H; O'Flaherty M; Raine R; Capewell S
    Circ Cardiovasc Qual Outcomes; 2013 Mar; 6(2):208-16. PubMed ID: 23481523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.